Literature DB >> 2532321

Sequence of the cDNA for the human fibroblast type interleukin-1 receptor.

A O Chua1, U Gubler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2532321      PMCID： PMC335251          DOI： 10.1093/nar/17.23.10114

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  7 in total

Review 1.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

2.  High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

Authors:  S D Yanofsky; D N Baldwin; J H Butler; F R Holden; J W Jacobs; P Balasubramanian; J P Chinn; S E Cwirla; E Peters-Bhatt; E A Whitehorn; E H Tate; A Akeson; T L Bowlin; W J Dower; R W Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

4.  Identification of the promoter region of human interleukin 1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression.

Authors:  K Ye; C A Dinarello; B D Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

5.  Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.

Authors:  J L McKenzie; W Egner; V L Calder; D N Hart
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

6.  Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.

Authors:  R M Burch; L C Mahan
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

7.  Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice.

Authors:  R C Bargou; M Y Mapara; C Zugck; P T Daniel; M Pawlita; H Döhner; B Dörken
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.